Anakinra biosimilar - Sunshine Guojian Pharmaceutical

Drug Profile

Anakinra biosimilar - Sunshine Guojian Pharmaceutical

Alternative Names: Interleukin-1 receptor antagonist - Sunshine Guojian Pharmaceutical

Latest Information Update: 04 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shanghai CP Guojian Pharmaceutical
  • Class Anti-inflammatories; Recombinant proteins
  • Mechanism of Action Interleukin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Dec 2011 Discontinued - Phase-III for Rheumatoid arthritis in China (SC)
  • 01 Jan 2008 Phase-III clinical trials in Rheumatoid arthritis in China (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top